Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California.
Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California.
JAMA. 2019 Feb 12;321(6):572-579. doi: 10.1001/jama.2019.0156.
Heart failure is an established risk factor for postoperative mortality, but how left ventricular ejection fraction and heart failure symptoms affect surgical outcomes is not fully described.
To determine the risk of postoperative mortality among patients with heart failure at various levels of echocardiographic (left ventricular systolic dysfunction) and clinical (symptoms) severity compared with those without heart failure and to evaluate how risk varies across levels of surgical complexity.
DESIGN, SETTING, AND PARTICIPANTS: US multisite retrospective cohort study of all adult patients receiving elective, noncardiac surgery in the Veterans Affairs Surgical Quality Improvement Project database from 2009 through 2016. A total of 609 735 patient records were identified and analyzed with 1 year of follow-up after having surgery (final study follow-up: September 1, 2017).
Heart failure, left ventricular ejection fraction, and presence of signs or symptoms of heart failure within 30 days of surgery.
The primary outcome was postoperative mortality at 90 days.
Outcome data from 47 997 patients with heart failure (7.9%; mean [SD] age, 68.6 [10.1] years; 1391 women [2.9%]) and 561 738 patients without heart failure (92.1%; mean [SD] age, 59.4 [13.4] years; 50 862 women [9.1%]) were analyzed. Compared with patients without heart failure, those with heart failure had a higher risk of 90-day postoperative mortality (2635 vs 6881 90-day deaths; crude mortality risk, 5.49% vs 1.22%; adjusted absolute risk difference [RD], 1.03% [95% CI, 0.91%-1.15%]; adjusted odds ratio [OR], 1.67 [95% CI, 1.57-1.76]). Compared with patients without heart failure, symptomatic patients with heart failure (n = 5906) had a higher risk (597 deaths [10.11%]; adjusted absolute RD, 2.37% [95% CI, 2.06%-2.57%]; adjusted OR, 2.37 [95% CI, 2.14-2.63]). Asymptomatic patients with heart failure (n = 42 091) (2038 deaths [crude risk, 4.84%]; adjusted absolute RD, 0.74% [95% CI, 0.63%-0.87%]; adjusted OR, 1.53 [95% CI, 1.44-1.63]), including the subset with preserved left ventricular systolic function (1144 deaths [4.42%]; adjusted absolute RD, 0.66% [95% CI, 0.54%-0.79%]; adjusted OR, 1.46 [95% CI, 1.35-1.57]), also experienced elevated risk.
Among patients undergoing elective noncardiac surgery, heart failure with or without symptoms was significantly associated with 90-day postoperative mortality. These data may be helpful in preoperative discussions with patients with heart failure undergoing noncardiac surgery.
心力衰竭是术后死亡的既定风险因素,但左心室射血分数和心力衰竭症状如何影响手术结果尚未完全阐明。
确定与无心力衰竭患者相比,在各种超声心动图(左心室收缩功能障碍)和临床(症状)严重程度水平下患有心力衰竭的患者在术后死亡率方面的风险,并评估手术复杂性级别之间的风险变化。
设计、地点和参与者:这是一项在美国退伍军人事务部外科质量改进项目数据库中进行的多地点回顾性队列研究,纳入了 2009 年至 2016 年期间接受择期非心脏手术的所有成年患者。共确定并分析了 609735 例患者的记录,并在手术后 1 年进行随访(最终研究随访:2017 年 9 月 1 日)。
心力衰竭、左心室射血分数以及术后 30 天内是否存在心力衰竭的体征或症状。
主要结局为术后 90 天的死亡率。
分析了 47997 例心力衰竭患者(7.9%;平均[SD]年龄 68.6[10.1]岁;1391 例女性[2.9%])和 561738 例无心力衰竭患者(92.1%;平均[SD]年龄 59.4[13.4]岁;50862 例女性[9.1%])的结局数据。与无心力衰竭的患者相比,心力衰竭患者的 90 天术后死亡率风险更高(2635 例与 6881 例 90 天死亡;粗死亡率风险 5.49%与 1.22%;调整绝对风险差异[RD] 1.03%[95%CI,0.91%-1.15%];调整比值比[OR] 1.67[95%CI,1.57-1.76])。与无心力衰竭的患者相比,有症状的心力衰竭患者(n=5906)风险更高(597 例死亡[10.11%];调整绝对 RD 2.37%[95%CI,2.06%-2.57%];调整 OR 2.37[95%CI,2.14%-2.63%])。无症状的心力衰竭患者(n=42091)(2038 例死亡[粗风险 4.84%];调整绝对 RD 0.74%[95%CI,0.63%-0.87%];调整 OR 1.53[95%CI,1.44-1.63]),包括左心室收缩功能保留的亚组(1144 例死亡[4.42%];调整绝对 RD 0.66%[95%CI,0.54%-0.79%];调整 OR 1.46[95%CI,1.35-1.57]),也经历了较高的风险。
在接受择期非心脏手术的患者中,无论是否存在症状,心力衰竭都与 90 天术后死亡率显著相关。这些数据可能有助于与接受非心脏手术的心力衰竭患者进行术前讨论。